These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1309073

  • 1. Modulation of fibrinolysis by thrombospondin.
    Mosher DF, Misenheimer TM, Stenflo J, Hogg PJ.
    Ann N Y Acad Sci; 1992 Dec 04; 667():64-9. PubMed ID: 1309073
    [Abstract] [Full Text] [Related]

  • 2. Thrombospondin is a slow tight-binding inhibitor of plasmin.
    Hogg PJ, Stenflo J, Mosher DF.
    Biochemistry; 1992 Jan 14; 31(1):265-9. PubMed ID: 1531022
    [Abstract] [Full Text] [Related]

  • 3. The effect of thrombospondin on invasion of fibrin gels by human A549 lung carcinoma.
    Hosokawa T, Muraishi A, Rothman VL, Papale M, Tuszynski GP.
    Oncol Res; 1993 Jan 14; 5(4-5):183-9. PubMed ID: 8305744
    [Abstract] [Full Text] [Related]

  • 4. Thrombospondin forms complexes with single-chain and two-chain forms of urokinase.
    Silverstein RL, Nachman RL, Pannell R, Gurewich V, Harpel PC.
    J Biol Chem; 1990 Jul 05; 265(19):11289-94. PubMed ID: 2141608
    [Abstract] [Full Text] [Related]

  • 5. Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator.
    Silverstein RL, Leung LL, Harpel PC, Nachman RL.
    J Clin Invest; 1984 Nov 05; 74(5):1625-33. PubMed ID: 6438154
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human C1-inhibitor prevents non-specific proteolysis by mutant pro-urokinase during optimal fibrinolysis.
    Gurewich V, Pannell R.
    Thromb Haemost; 2009 Aug 05; 102(2):279-86. PubMed ID: 19652878
    [Abstract] [Full Text] [Related]

  • 7. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
    Loza JP, Gurewich V, Johnstone M, Pannell R.
    Thromb Haemost; 1994 Mar 05; 71(3):347-52. PubMed ID: 8029800
    [Abstract] [Full Text] [Related]

  • 8. Urokinase and non-urokinase fibrinolytic activity in protease-inhibitor-deprived plasma, assayed by a fibrin micro-plate method.
    Fossum S, Hoem NO.
    Immunopharmacology; 1996 May 05; 32(1-3):119-21. PubMed ID: 8796286
    [Abstract] [Full Text] [Related]

  • 9. Quebec platelet disorder: features, pathogenesis and treatment.
    Diamandis M, Veljkovic DK, Maurer-Spurej E, Rivard GE, Hayward CP.
    Blood Coagul Fibrinolysis; 2008 Mar 05; 19(2):109-19. PubMed ID: 18277131
    [Abstract] [Full Text] [Related]

  • 10. Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis.
    Bai X, Weitz JI, Gross PL.
    Thromb Haemost; 2009 Dec 05; 102(6):1212-8. PubMed ID: 19967153
    [Abstract] [Full Text] [Related]

  • 11. Activated platelets increase fibrinolysis of mesenchymal progenitor cells.
    Agis H, Kandler B, Fischer MB, Watzek G, Gruber R.
    J Orthop Res; 2009 Jul 05; 27(7):972-80. PubMed ID: 19030175
    [Abstract] [Full Text] [Related]

  • 12. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ, Stafford AR, Leslie BA, Kim PY, Vaezzadeh N, Ni R, Fredenburgh JC, Weitz JI.
    Thromb Haemost; 2015 Jun 05; 113(6):1278-88. PubMed ID: 25789495
    [Abstract] [Full Text] [Related]

  • 13. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 05; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 14. Physiology of thrombospondin.
    Mosher DF.
    Annu Rev Med; 1990 Aug 05; 41():85-97. PubMed ID: 1691903
    [Abstract] [Full Text] [Related]

  • 15. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
    Aoki N, Moroi M, Tachiya K.
    Thromb Haemost; 1978 Feb 28; 39(1):22-31. PubMed ID: 77050
    [Abstract] [Full Text] [Related]

  • 16. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P, Kant KS, Allen C, Pollak VE.
    J Lab Clin Med; 1984 Dec 28; 104(6):962-76. PubMed ID: 6239000
    [Abstract] [Full Text] [Related]

  • 17. Identification of possible inhibitory reactive centers in thrombospondin 1 that may bind cathepsin G and neutrophil elastase.
    Hogg PJ, Jiménez BM, Chesterman CN.
    Biochemistry; 1994 May 31; 33(21):6531-7. PubMed ID: 8204588
    [Abstract] [Full Text] [Related]

  • 18. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J.
    Dan Med Bull; 1990 Jun 31; 37(3):210-34. PubMed ID: 2192835
    [Abstract] [Full Text] [Related]

  • 19. Modulation of endothelial cells fibrinolytic activity by platelets.
    Menashi S, He L, Soria C, Soria J, Thomaidis A, Legrand Y.
    Thromb Haemost; 1991 Jan 23; 65(1):77-81. PubMed ID: 2024242
    [Abstract] [Full Text] [Related]

  • 20. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W, Jurkowski J, Ostrowska H, Worowski K.
    Rocz Akad Med Bialymst (1989); 1991 Jan 23; 33-34():53-66. PubMed ID: 2979011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.